Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

David M. Rose(Vanderbilt University Medical Center), C. Wright Pinson(Vanderbilt University Medical Center), Charles D. Blanke(SWOG Cancer Research Network), Amy T. Rose(Vanderbilt University Medical Center), Taylor K. Blair(Vanderbilt University Medical Center), J. Kelly Wright(Vanderbilt University Medical Center), William C. Chapman(Washington University in St. Louis), Murray Mazer(Vanderbilt University Medical Center), Andrew Brockenbrough(Vanderbilt University Medical Center), Jacob P. Debelak(Vanderbilt University Medical Center), Steven G. Meranze(Vanderbilt University Medical Center)
The American Journal of Surgery
May 1, 1999
10.1016/s0002-9610(99)00069-0
Cited by 49

Related Papers

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <i>KIT</i>
|Journal of Clinical Oncology|2008|1k
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
|JAMA|2017|891
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636